These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 30049630)
1. N-terminal domain of Schmallenberg virus envelope protein Gc delivered by recombinant equine herpesvirus type 1 and modified vaccinia virus Ankara: Immunogenicity and protective efficacy in cattle. Wernike K; Mundt A; Link EK; Aebischer A; Schlotthauer F; Sutter G; Fux R; Beer M Vaccine; 2018 Aug; 36(34):5116-5123. PubMed ID: 30049630 [TBL] [Abstract][Full Text] [Related]
2. The N-terminal domain of Schmallenberg virus envelope protein Gc is highly immunogenic and can provide protection from infection. Wernike K; Aebischer A; Roman-Sosa G; Beer M Sci Rep; 2017 Feb; 7():42500. PubMed ID: 28211908 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and efficacy of Schmallenberg virus envelope glycoprotein subunit vaccines. Endalew AD; Faburay B; Trujillo JD; Gaudreault NN; Davis AS; Shivanna V; Sunwoo SY; Ma W; Drolet BS; McVey DS; Morozov I; Wilson WC; Richt JA J Vet Sci; 2019 Nov; 20(6):e58. PubMed ID: 31775185 [TBL] [Abstract][Full Text] [Related]
4. Deletion mutants of Schmallenberg virus are avirulent and protect from virus challenge. Kraatz F; Wernike K; Hechinger S; König P; Granzow H; Reimann I; Beer M J Virol; 2015 Feb; 89(3):1825-37. PubMed ID: 25410877 [TBL] [Abstract][Full Text] [Related]
5. DNA vaccination regimes against Schmallenberg virus infection in IFNAR Boshra HY; Charro D; Lorenzo G; Sánchez I; Lazaro B; Brun A; Abrescia NG Antiviral Res; 2017 May; 141():107-115. PubMed ID: 28235558 [TBL] [Abstract][Full Text] [Related]
7. Evaluating the protective efficacy of a trivalent vaccine containing Akabane virus, Aino virus and Chuzan virus against Schmallenberg virus infection. Hechinger S; Wernike K; Beer M Vet Res; 2013 Dec; 44(1):114. PubMed ID: 24313924 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the humoral immune response against the envelope glycoprotein Gc of Schmallenberg virus reveals a domain located at the amino terminus targeted by mAbs with neutralizing activity. Roman-Sosa G; Brocchi E; Schirrmeier H; Wernike K; Schelp C; Beer M J Gen Virol; 2016 Mar; 97(3):571-580. PubMed ID: 26684324 [TBL] [Abstract][Full Text] [Related]
9. An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep. Said A; Elmanzalawy M; Ma G; Damiani AM; Osterrieder N Virol J; 2017 Aug; 14(1):154. PubMed ID: 28807043 [TBL] [Abstract][Full Text] [Related]
10. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice. Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844 [TBL] [Abstract][Full Text] [Related]
11. High genetic variability of Schmallenberg virus M-segment leads to efficient immune escape from neutralizing antibodies. Wernike K; Reimann I; Banyard AC; Kraatz F; La Rocca SA; Hoffmann B; McGowan S; Hechinger S; Choudhury B; Aebischer A; Steinbach F; Beer M PLoS Pathog; 2021 Jan; 17(1):e1009247. PubMed ID: 33497419 [TBL] [Abstract][Full Text] [Related]
12. Schmallenberg virus neutralising antibody responses in sheep. Jones S; Eden L; McKay H; Bollard N; Dunham S; Davies P; Tarlinton R BMC Vet Res; 2019 Nov; 15(1):426. PubMed ID: 31779623 [TBL] [Abstract][Full Text] [Related]
13. Persistence of the protective immunity and kinetics of the isotype specific antibody response against the viral nucleocapsid protein after experimental Schmallenberg virus infection of sheep. Poskin A; Verite S; Comtet L; Van der Stede Y; Cay B; De Regge N Vet Res; 2015 Oct; 46():119. PubMed ID: 26472116 [TBL] [Abstract][Full Text] [Related]
14. Development of within-herd immunity and long-term persistence of antibodies against Schmallenberg virus in naturally infected cattle. Wernike K; Holsteg M; Szillat KP; Beer M BMC Vet Res; 2018 Nov; 14(1):368. PubMed ID: 30477532 [TBL] [Abstract][Full Text] [Related]
15. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination. Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens. Volz A; Lim S; Kaserer M; Lülf A; Marr L; Jany S; Deeg CA; Pijlman GP; Koraka P; Osterhaus AD; Martina BE; Sutter G Vaccine; 2016 Apr; 34(16):1915-26. PubMed ID: 26939903 [TBL] [Abstract][Full Text] [Related]
17. Serosurveillance of Schmallenberg virus in Switzerland using bulk tank milk samples. Balmer S; Vögtlin A; Thür B; Büchi M; Abril C; Houmard M; Danuser J; Schwermer H Prev Vet Med; 2014 Oct; 116(4):370-9. PubMed ID: 24794645 [TBL] [Abstract][Full Text] [Related]
18. Detection of Schmallenberg virus serum neutralising antibodies. Mansfield KL; La Rocca SA; Khatri M; Johnson N; Steinbach F; Fooks AR J Virol Methods; 2013 Mar; 188(1-2):139-44. PubMed ID: 23201289 [TBL] [Abstract][Full Text] [Related]
19. International proficiency trial demonstrates reliable Schmallenberg virus infection diagnosis in endemic and non-affected countries. Wernike K; Beer M PLoS One; 2019; 14(6):e0219054. PubMed ID: 31247024 [TBL] [Abstract][Full Text] [Related]
20. Incursion of Schmallenberg virus into Great Britain in 2011 and emergence of variant sequences in 2016. McGowan SL; La Rocca SA; Grierson SS; Dastjerdi A; Choudhury B; Steinbach F Vet J; 2018 Apr; 234():77-84. PubMed ID: 29680399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]